We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-1.81%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5.56B
AUM Growth
+$94.2M
(+1.7%)
Cap. Flow
+$293M
Cap. Flow
% of AUM
5.28%
Top 10 Holdings %
Top 10 Hldgs %
35.79%
Holding
4,002
New
390
Increased
2,050
Reduced
771
Closed
169
Avg Time Held Equity + Options
4.8
years
Top 10 Avg Time Held Equity + Options
3.5
years
Top 20 Avg Time Held Equity + Options
4.4
years
Avg Time Held Equity only
4.8
years
Top 10 Avg Time Held Equity only
3.5
years
Top 20 Avg Time Held Equity only
4.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$160M |
| 2 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$59.5M |
| 3 |
VictoryShares Free Cash Flow ETF
VFLO
|
+$57M |
| 4 |
JPMorgan International Bond Opportunities ETF
JPIB
|
+$43M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$19.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$180M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$51M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$3.59M |
| 4 |
CVB Financial
CVBF
|
+$3.2M |
| 5 |
iShares International Select Dividend ETF
IDV
|
+$3.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.36% |
| 2 | Technology | 16.32% |
| 3 | Healthcare | 6.92% |
| 4 | Financials | 6.46% |
| 5 | Communication Services | 5.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3476
Iovance Biotherapeutics
IOVA
$6.3B
| $1.17K | ﹤0.01% |
+332
| New | +$1.06K |
2026 Q1
0 quarters
|
|
3477
FS Specialty Lending Fund
FSSL
$872M
| $1.16K | ﹤0.01% |
+93
| New | +$1.21K |
2026 Q1
0 quarters
|
|
3478
Bank of N.T. Butterfield & Son
NTB
$2.32B
| $1.16K | ﹤0.01% |
22
+15
| +214% | +$770 |
2025 Q4
1 quarter
|
|
3479
Arlo Technologies
ARLO
$1.34B
| $1.15K | ﹤0.01% |
81
+27
| +50% | +$361 |
2022 Q4
13 quarters
|
|
3480
Angel Studios
ANGX
$678M
| $1.14K | ﹤0.01% |
374
-1,680
| -82% | -$6.43K |
2025 Q3
2 quarters
|
|
3481
Mama's Creations
MAMA
$625M
| $1.14K | ﹤0.01% |
74
+63
| +573% | +$956 |
2025 Q3
2 quarters
|
|
3482
Geron
GERN
$771M
| $1.13K | ﹤0.01% |
+760
| New | +$1.16K |
2026 Q1
0 quarters
|
|
3483
Magnera Corp
MAGN
$406M
| $1.13K | ﹤0.01% |
119
-14
| -11% | -$179 |
2024 Q4
5 quarters
|
|
3484
dLocal
DLO
$4.43B
| $1.13K | ﹤0.01% |
+87
| New | +$1.13K |
2026 Q1
0 quarters
|
|
3485
MFA Financial
MFA
$674M
| $1.12K | ﹤0.01% |
+117
| New | +$1.15K |
2026 Q1
0 quarters
|
|
3486
Gorman-Rupp
GRC
$1.92B
| $1.12K | ﹤0.01% |
18
| – | – |
2023 Q2
11 quarters
|
|
3487
RCI Hospitality Holdings
RICK
$201M
| $1.12K | ﹤0.01% |
+49
| New | +$1.15K |
2026 Q1
0 quarters
|
|
3488
Phathom Pharmaceuticals
PHAT
$595M
| $1.11K | ﹤0.01% |
100
| – | – |
2025 Q1
4 quarters
|
|
3489
Arcutis Biotherapeutics
ARQT
$3.62B
| $1.11K | ﹤0.01% |
47
+45
| +2,250% | +$1.15K |
2025 Q4
1 quarter
|
|
3490
Palladyne AI
PDYN
$199M
| $1.1K | ﹤0.01% |
+182
| New | +$1.23K |
2026 Q1
0 quarters
|
|
3491
LSI Industries
LYTS
$762M
| $1.1K | ﹤0.01% |
+59
| New | +$1.22K |
2026 Q1
0 quarters
|
|
3492
Shutterstock
SSTK
$167M
| $1.1K | ﹤0.01% |
66
-47
| -42% | -$828 |
2020 Q1
24 quarters
|
|
3493
Neighborhood Intelligence Inc
NXH
$188M
| $1.09K | ﹤0.01% |
236
-270
| -53% | -$1.51K |
2021 Q1
20 quarters
|
|
3494
FerroAtlántica
GSM
$761M
| $1.09K | ﹤0.01% |
265
+36
| +16% | +$173 |
2025 Q3
2 quarters
|
|
3495
Frontier Group Holdings
ULCC
$1.17B
| $1.09K | ﹤0.01% |
309
-35
| -10% | -$160 |
2022 Q2
15 quarters
|
|
3496
Marcus & Millichap
MMI
$1.08B
| $1.09K | ﹤0.01% |
41
+30
| +273% | +$789 |
2023 Q4
9 quarters
|
|
3497
Franklin FTSE Japan ETF
FLJP
$4.23B
| $1.08K | ﹤0.01% |
30
| – | – |
2023 Q1
12 quarters
|
|
3498
Supernus Pharmaceuticals
SUPN
$2.27B
| $1.08K | ﹤0.01% |
21
-75
| -78% | -$3.82K |
2022 Q3
14 quarters
|
|
3499
E.W. Scripps
SSP
$257M
| $1.08K | ﹤0.01% |
290
| – | – |
2025 Q4
1 quarter
|
|
3500
Liberty Global Class A
LBTYA
$2.74B
| $1.08K | ﹤0.01% |
+89
| New | +$1.04K |
2026 Q1
0 quarters
|
|
Similar funds
Parallel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Parallel Advisors held 4,002 positions worth $5.56B, up 1.7% from $5.47B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors deployed $293M of net new capital in Q1 2026, opening 390 new positions and adding to 2,050 existing holdings. Its largest new stake was JPMorgan International Bond Opportunities ETF: 883,008 shares worth $42.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, up from 48% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P Total US Stock Market ETF, an estimated $180M trimmed.
- Parallel Advisors's largest Q1 2026 buy was JPMorgan International Bond Opportunities ETF: 883,008 shares worth $42.2M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $160M increase.
- Parallel Advisors's biggest Q1 2026 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $180M.
- Parallel Advisors fully exited iShares 1-3 Year International Treasury Bond ETF in Q1 2026, selling an estimated $741K.
- Parallel Advisors's ten largest holdings make up 36% of its $5.56B portfolio in Q1 2026.
- Parallel Advisors opened 390 new positions and closed 169 in Q1 2026.
- Parallel Advisors's portfolio value rose 1.7% quarter-over-quarter to $5.56B.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.